ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 40

Syndecan-4 Regulates Activation of WNT Signaling in Chondrocytes

Jessica Bertrand1, Richard Stange2, Giovanna Nalesso3, Joanna Sherwood3, Lars Godmann4, Frank Echtermeyer5, Francesco Dell'Accio6 and Thomas Pap4, 1Institute of Experimental Musculoskeletal Medicine (IEMM), University Hospital Münster, Münster, Germany, 2Dept. of Trauma, Hand and Reconstructive Surgery, University Hospital Münster, Münster, Germany, 3Centre for Experimental Medicine and Rheumatology, Queen Mary University London, London, United Kingdom, 4Institute of Experimental Muskuloskeletal Medicine, University Hospital Münster, Münster, Germany, 5Dept. of Anaesthesiology and Intensive Care Medicine, University hospital Hanover, Hanover, Germany, 6William Harvey Research Institute, Barts and the London Queen Mary's School of Medicine and Dentistry, Centre for Experimental Medicine and Rheumatology, London, United Kingdom

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: cartilage, osteoarthritis and signal transduction

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Biology and Pathology of Bone and Joint

Session Type: Abstract Submissions (ACR)

Background/Purpose: Blockade of syndecan-4 (Sdc4) signaling protects mice from cartilage degradation in experimentally induced osteoarthritis (OA). Cartilage damage results in changes of chondrocyte phenotype induced by various signaling pathways including the activation of WNT signaling. Here, we hypothesized that Sdc4 modulates chondrocyte phenotype by the specific modulation of WNT signaling.

Methods: In vitro analyses were performed using neonatal wild type (wt) and Sdc4-/- chondrocytes, or a blocking Sdc4 antibody on wt chondrocytes. The influence of 100 ng/ ml WNT3a on glycosaminoglycan (GAG) production was analyzed using alcian blue staining of micromass cultures. The expression of chondrocyte marker genes (aggrecan, collagen 2, MMP13) was measured by quantitative RT-PCR. The effects of WNT3a on canonical and noncanonical WNT signaling were analyzed using Western Blot detection of ß-catenin, pLRP-6, pCamKII and pJNK and a TCF/LEF reporter assay. To investigate the in vivo relevance of the investigated pathways induction of OA in wt and Sdc4-/- mice was performed using the DMM model and stainings for ß-catenin and pCamKII were performed.

Results:

Micromass cultures revealed a higher basal GAG production by Sdc4-/- than wt chondrocytes. Furthermore, WNT3a stimulation led to a decrease in GAG in wt, which was not observed in Sdc4-/- chondrocytes. These findings were confirmed by a 10x higher basal production of aggrecan and collagen 2 in Sdc4-/- compared to wt chondrocytes. The expression of both genes was 10 fold increased by stimulation with WNT3a, whereas WNT3a led to a decrease in the expression of both genes in wt chondrocytes. Inverse results were found for MMP13, which was significantly less expressed in Sdc4-/- chondrocytes and was not upregulated upon WNT3a stimulation. Western blot analyses of canonical WNT signaling showed that ß catenin is strongly reduced and not upregulated upon stimulation with WNT3a in Sdc4-/- chondrocytes. Confirming these findings we also found less phosphorylation of LRP6 and less activation of the TCF/Lef reporter upon WNT3a stimulation in Sdc4-/- chondrocytes. Noncanonical WNT signaling was increased in Sdc4-/- under basal conditions, but decreased upon WNT3a stimulation in Sdc4-/- and increased in wt chondrocytes. The same blockade of canonical and downregulation of noncanonical WNT signaling upon WNT stimulation were obtained by using a blocking Sdc-4 antibody. In vivo analyses of canonical WNT signaling confirmed the decreased basal activation and the missing increase after induction of OA in Sdc4-/- mice. 

Conclusion: We conclude from our data that Sdc4 is a major regulator of cellular response to WNT through the prevention of the induction of canonical WNT signaling. Therefore, we suggest that the blockade of Sdc-4 protects from OA induced changes in chondrocyte phenotype by inhibiting WNT induced differentiation of chondrocytes.


Disclosure:

J. Bertrand,
None;

R. Stange,
None;

G. Nalesso,
None;

J. Sherwood,
None;

L. Godmann,
None;

F. Echtermeyer,
None;

F. Dell’Accio,
None;

T. Pap,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/syndecan-4-regulates-activation-of-wnt-signaling-in-chondrocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology